TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive NCI Contracts: Advisors OK Renewal Of chemoprevention Contracts By DCPC September 6, 1996
